Form 4 for NRIX Nurix Therapeutics, Inc.
Accepted 2024-07-18 00:00:00 ET · period of report 2024-07-17 · accession 0001549595-24-000100 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-18 | 2024-07-17 | NRIX | Kunkel Lori Anne | Dir | G - Gift | $0.00 | -54.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-17 | G | D | 54,027 | $0.00 | 0 | D | — | — |